APR 25, 2019 10:30 AM PDT

Advances in Point-Of-Care Testing for Infectious Diseases

Sponsored by: Chembio
Speakers
  • Global Marketing Director, Chembio Diagnostic Systems
    Biography
      Krishnan Allampallam joined Chembio Diagnostic Systems, Inc about two years and serves as Global Director of Marketing. Krishnan has spent over 15+ years in the biotechnology industry. Before beginning his career in biotech, Krishnan focused his research in the field of oncology and has authored and co-authored multiple publications, abstracts and book chapters in peer reviewed journals. He received his Ph.D. from University of Toledo Medical Center in 1996 and did post-doctoral research at The Cleveland Clinic and Rush University Medical Center. Currently Krishnan is the Global Director of Marketing at Chembio Diagnostics, a New York Based public company focused on point of care rapid diagnostics. Prior to Chembio, Krishnan held various leadership positions in marketing and global product management.
    • Vice President, Research & Development, Chembio Diagnostic Systems
      Biography
        Paul Lambotte joined Chembio Diagnostic Systems, Inc. in December 2014, and serves as Vice President of Product Development. Prior to joining the company, Mr. Lambotte was President of PLC Inc., a POC product development consulting company. He previously served as Chief Science Officer at Axxin Pty Ltd, held positions of VP of R&D and Business Development at Quidel Corporation, and held a number of positions at Beckman Coulter and Hybritech Inc. Mr. Lambotte is the inventor of several patents in the field of rapid, point-of-care diagnostic products. He received a Master in Biochemistry and a PhD in Protein Biochemistry from the University of Mons, Belgium, and did post-doctoral work at the Ludwig Institute for Cancer research in Brussels, Belgium.

      Abstract

      Point-of-care testing (POCT) is diagnostic testing at the time and place of patient care in a physician’s office, an ambulance, a mobile clinic, at home or in hospital.  Rapid POC testing yields actionable results and rapid treatment of patients. Until now, POC tests based on lateral flow technology have suffered of limitations in sensitivity, specificity, the lack of multiplexing and the questionable reliability of results obtained visually by the users.  To address these limitations, Chembio has developed an advanced rapid POC testing solution, the DPP® System combining its Dual Path Platform (DPP®) disposable cartridges with its optical analyzer (DPP® Reader). The DPP® System provides users with a complete solution for rapid testing at the Point of Care. The DPP® System requires one small sample from the patient, minimum hands-on time, short turn-around time, and provides multiple results in one operation, free from human bias.  During the webinar “Advances in POC Testing for infectious diseases”, we will introduce the advanced DPP® technology, the optical analyzer, and demonstrate the power of the DPP® Systems in detecting multiple biomarkers at the Point of Care. 

      Learning Objectives: 

      1. Current needs and status of POC diagnostics in infectious diseases
      2. What is DPP technology and how it differs from the current lateral flow technology
      3. Application of DPP technology in multiplex testing
      4. How the combination of DPP technology and  a hand held digital reader in POC testing improves testing accuracy


      Show Resources
      You May Also Like
      MAY 11, 2021 10:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      MAY 11, 2021 10:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      APR 01, 2021 8:00 AM PDT
      C.E. CREDITS
      APR 01, 2021 8:00 AM PDT
      Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
      MAR 16, 2021 10:00 AM PDT
      C.E. CREDITS
      MAR 16, 2021 10:00 AM PDT
      Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
      NOV 16, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      FEB 24, 2021 10:00 AM PST
      C.E. CREDITS
      FEB 24, 2021 10:00 AM PST
      DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
      APR 25, 2019 10:30 AM PDT

      Advances in Point-Of-Care Testing for Infectious Diseases

      Sponsored by: Chembio

      Specialty

      Clinical Diagnostics

      Laboratory Testing

      Immunology

      Microbiology

      Infectious Disease

      Cancer Diagnostics

      Antibodies

      Molecular Biology

      Health

      Molecular Diagnostics

      Protein

      Hematology

      Cancer Research

      Medical Microbiology

      Brain

      Geography

      North America84%

      Asia11%

      Europe5%

      Registration Source

      Website Visitors100%

      Job Title

      Medical Laboratory Technician31%

      Executive19%

      Medical Doctor/Specialist13%

      Lab Management13%

      Clinical Laboratory Scientist6%

      Facility/Department Manager6%

      Research Scientist6%

      Scientist6%

      Organization

      Hospital32%

      Clinical Laboratory26%

      Diagnostic Company11%

      Academic Institution11%

      Manufacturer - Other5%

      Contract Research Organization (Cro)5%

      Medical Device Company5%

      Other5%


      Show Resources
      Loading Comments...
      Show Resources
      Attendees
      • See more